Company Data
Stoke Therapeutics Inc.
Ticker
STOK
Current Price
$11.86 -1.5%
Market Cap
$647.5M
Price Target
Refer to Report
Volume
545.1K
52wk Range
$5.35 - $16.15
Overview
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels.